Traxion Sab De Cv Ord Shs GRPOF

This news this morning is AMAZING!

[Jordantrademark]

This is one step closer to big...... Big... $$$$.... We are talking the big boy league here, it's companies like this that go from 50cents to litterally 10 bucks in a short period of time, I've seen many Bio plays go parabolic that I missed out on. LIVER CANCER cure soon guys and gals..... Lots of steps involved but if Tetra can keep up the solid work we will be in the dollars. Insiders bought in higher months ago, showing signs of excitement and trust in the company. Big news to come, if you aren't in this one when the big halt comes you won't want to get in at 1 buck... Then it will turn to 3 bucks, then in 10 years it tetra will just be a story of how you "once" held that stock! Hold on tight Hepatocellular carcinoma (HCC), also known as primary liver cancer, is the most common form of liver cancer and is responsible for 80 percent of the primary malignant liver tumors in adults. In addition to quality of life benefits to cancer patients, based on preclinical research, HCC011 should also have antitumor effects. The Phase 2 study of HCC011 will target patients with disease progression on Sorafenib, have measurable disease, and Child-Pugh Class A liver impairment. The Phase 2 trial will consist of a single arm. Patients will receive the HCC011 by inhalation three times daily, in combination with Sorafenib, until disease progression or unacceptable toxicity. The study design is similar to the ones used by recent drugs seeking accelerated approval.